These studies proved the adjuvant effect of IL-22 in combination with the vaccine to induce the IFN-γ cytokine response, while in the TB vaccine model, we didn't achieve such a result here, and this controversy may be due to the type of antigen or doses of IL-22 in this study. Here, IL22 is linked to tuberculosis.